Open AccessDaratumumab Triple Combination Delays Disease Progression
Author(s) -
Mark L. Fuerst
Publication year - 2020
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000653376.41738.6c
Subject(s) - carfilzomib , lenalidomide , daratumumab , medicine , multiple myeloma , dexamethasone , bortezomib , oncology , regimen , refractory (planetary science) , thalidomide , ixazomib , population , proteasome inhibitor , pharmacology , physics , environmental health , astrobiology